Vleminckx K, Kemler R: Cadherins and tissue formation: integrating adhesion and signaling. Bioessays. 1999, 21: 211-220. 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.0.CO;2-P.
Article
CAS
PubMed
Google Scholar
Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hiro-hashi S: Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA. 1995, 92: 7416-7419.
Article
CAS
PubMed
PubMed Central
Google Scholar
Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB: E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995, 55: 5195-5199.
CAS
PubMed
Google Scholar
Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia DH: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000, 2: 84-89. 10.1038/35000034.
Article
CAS
PubMed
Google Scholar
Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, Van Roy F: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001, 7: 1267-1278. 10.1016/S1097-2765(01)00260-X.
Article
CAS
PubMed
Google Scholar
Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, De Herreros AG, Dedhar S: Inhibition of integrin linked kinase (ILK) suppresses beta-catenin–Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene. 2001, 20: 133-140. 10.1038/sj.onc.1204052.
Article
CAS
PubMed
Google Scholar
Berx G, Becker KF, Hofler H, Van Roy F: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998, 12: 226-237. 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D.
Article
CAS
PubMed
Google Scholar
Berx G, Cleton-Jansen AM, Strumane K, De Leeuw WJF, Nollet F, Van Roy F, Cornelisse C: E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 1996, 13: 1919-1925.
CAS
PubMed
Google Scholar
Berx G, Cleton-Jansen AM, Nollet F, De Leeuw WJF, Van de Vijver MJ, Cornelisse C, Van Roy F: E-cadherin is a tumour invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995, 14: 6107-6115.
CAS
PubMed
PubMed Central
Google Scholar
Jones PA, Laird PW: Cancer epigenetics comes of age. Nat Genet. 1999, 21: 163-167. 10.1038/5947.
Article
CAS
PubMed
Google Scholar
Cleton-Jansen AM, Callen DF, Seshadri R, Goldup S, McCallum B, Crawford J, Powell JA, Settasatian C, van Beerendonk H, Moer-land EW, Smit VT, Harris WH, Millis R, Morgan NV, Barnes D, Mathew CG, Cornelisse CJ: Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res. 2001, 61: 1171-1177.
CAS
PubMed
Google Scholar
Tischfield JA: Loss of heterozygosity or: how I learned to stop worrying and love mitotic recombination. Am J Hum Genet. 1997, 61: 995-999. 10.1086/301617.
Article
CAS
PubMed
PubMed Central
Google Scholar
Devilee P, Cleton-Jansen AM, Cornelisse CJ: Ever since Knudson. Trends Genet. 2001, 17: 569-573. 10.1016/S0168-9525(01)02416-7.
Article
CAS
PubMed
Google Scholar
Beavon IR: Regulation of E-cadherin: does hypoxia initiate the metastatic cascade?. Mol Pathol. 1999, 52: 179-188.
Article
CAS
PubMed
PubMed Central
Google Scholar
De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM: Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol. 1997, 183: 404-411. 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9.
Article
CAS
PubMed
Google Scholar
Vos CB, Cleton-Jansen AM, Berx G, De Leeuw WJ, ter Haar NT, Van Roy F, Cornelisse CJ, Peterse JL, Van de Vijver MJ: E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer. 1997, 76: 1131-1133.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vos CBJ, ter Haar NT, Rosenberg C, Peterse JL, Cleton-Jansen A-M, Cornelisse CJ, Van de Vijver MJ: Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histological type. Br J Cancer. 1999, 81: 1410-1418. 10.1038/sj.bjc.6693372.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vleminckx K, Vakaet L, Mareel M, Fiers W, Van Roy F: Genetic manipulations of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991, 66: 107-119.
Article
CAS
PubMed
Google Scholar
Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998, 392: 190-193. 10.1038/32433.
Article
CAS
PubMed
Google Scholar
Birchmeier W, Behrens J: Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994, 1198: 11-26. 10.1016/0304-419X(94)90003-5.
CAS
PubMed
Google Scholar
Lakhani SR, Collins N, Sloane JP, Stratton MR: Loss of heterozy-gosity in lobular carcinoma in situ of the breast. J Clin Pathol. 1995, 48M: M74-M78.
Google Scholar
Lakhani SR: The transition from hyperplasia to invasive carcinoma of the breast. J Pathol. 1999, 187: 272-278. 10.1002/(SICI)1096-9896(199902)187:3<272::AID-PATH265>3.0.CO;2-2.
Article
CAS
PubMed
Google Scholar
Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, Hanby A, Sheer D: Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 1999, 59: 1433-1436.
CAS
PubMed
Google Scholar
Buerger H, Simon R, Schafer KL, Diallo R, Littmann R, Poremba C, Van Diest PJ, Dockhorn-Dworniczak B, Bocker W: Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol. 2000, 53: 118-121. 10.1136/mp.53.3.118.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE: E-cadherin germline mutations in familial gastric cancer. Nature. 1998, 392: 402-405. 10.1038/32918.
Article
CAS
PubMed
Google Scholar
Richards FM, McKee SA, Rajpar MH, Cole TR, Evans DG, Jankowski JA, McKeown C, Sanders DS, Maher ER: Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet. 1999, 8: 607-610. 10.1093/hmg/8.4.607.
Article
CAS
PubMed
Google Scholar
Rahman N, Stone JG, Coleman G, Gusterson B, Seal S, Marossy A, Lakhani SR, Ward A, Nash A, McKinna A, A'Hern R, Stratton MR, Houlston RS: Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer. 2000, 82: 568-570. 10.1054/bjoc.1999.0965.
Article
CAS
PubMed
PubMed Central
Google Scholar
Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S: Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000, 26: 16-17. 10.1038/79120.
Article
CAS
PubMed
Google Scholar